Kostas Biliouris
Analyst
Oppenheimer
Equibles does not estimate personal net worth.
About Kostas Biliouris
Kostas Biliouris is recorded as Analyst at Oppenheimer. Kostas Biliouris has spoken on 2 earnings calls across 2 companies, most recently for Sarepta Therapeutics, Inc. on August 5, 2026. Those appearances were for Sarepta Therapeutics, Inc. (SRPT) and Satellos Bioscience Inc. (MSLE). The companies whose calls Kostas Biliouris spoke on are classified in the Healthcare sector.
Kostas Biliouris on recent calls
“Based on our discussions, there is a high number of investors who are very interested in the DM1 and FSHD program but are hesitating to underwrite the DMD pipeline risk.”
“Given that the MRI muscle fat fraction data are very promising here, very telling, can you elaborate a little bit on these endpoints?”
Affiliation history
-
Oppenheimer
Analyst
Transcript header (unverified)
Current